Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
27.75
-0.03 (-0.11%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
3 Standout Stocks That Crushed Q4 Earnings Estimates
January 31, 2024
These three stocks crushing Q4 earnings are on the rise after the companies behind them closed the year with a bang.
Via
InvestorPlace
Peeling Back The Layers: Exploring Pfizer Through Analyst Insights
January 31, 2024
Via
Benzinga
Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts
January 31, 2024
The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won't Floor Novo, Eli Shares
January 31, 2024
Eli Lilly to report strong Q4 earnings thanks to successful diabetes treatments, while rivals like Novo Nordisk and Pfizer are also vying for a share of the weight-loss market.
Via
Benzinga
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
Colds, flu and RSV aren't the only viral illnesses people have to worry about this winter. A new variant of COVID-19 is rapidly spreading, reminding the world of just how dangerous this virus is.
Via
Benzinga
Exposures
COVID-19
Why NYSE:PFE is a Top Pick for Dividend Investors.
January 30, 2024
Balancing Dividends and Fundamentals: The Case of PFIZER INC (NYSE:PFE).
Via
Chartmill
Where Will Pfizer Be in 10 Years?
January 28, 2024
Pfizer stock has dropped about 50% from its peak.
Via
The Motley Fool
Best Income Stocks 2024
January 31, 2024
The pros and cons of 7 companies in 4 different sectors.
Via
Talk Markets
Pfizer (PFE) Q4 2023 Earnings Call Transcript
January 30, 2024
PFE earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Pfizer Stock Was Jumping Today, but Then Gave Up Its Gains
January 30, 2024
The drugmaker's Q4 results were better than many expected, but still not good enough to spark a sustained rally.
Via
The Motley Fool
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
US Stocks Edge Lower; Pfizer Reports Surprise Profit
January 30, 2024
U.S. stocks traded slightly lower this morning on Tuesday. Following the market opening Tuesday, the Dow traded down 0.04% to 38,316.43 while the NASDAQ fell 0.12% to 15,608.59. The S&P 500 also fell,...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Pfizer Q4 Results: $14.25B In Revenue And EPS Of $0.1, Exceeding Forecasts
January 30, 2024
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
Via
Talk Markets
Pfizer Reports Surprise Profit Despite Continued Covid Sales Downfall
January 30, 2024
The company also reiterated its guidance for the full year.
Via
Investor's Business Daily
Exposures
COVID-19
Pfizer Surprises With Q4 Profit Despite Muted COVID Products Demand, Sticks To 2024 Guidance
January 30, 2024
Pfizer's Q4 2023 financial report: adjusted EPS beats estimates at $0.10, FY2023 EPS down 72%, Q4 sales decline 41% to $14.25B. CEO's positive outlook and reaffirmed 2024 guidance.
Via
Benzinga
Exposures
COVID-19
US Stocks Hold Steady Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of 'Big Air Pocket' In Pivotal Trading Week
January 30, 2024
After a record run, U.S. stocks could pause for a breather ahead of the tech earnings deluge that is expected to hit the Street this week.
Via
Benzinga
Tuesday Talk: A Good Month - Two Days To Go
January 30, 2024
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the
Via
Talk Markets
Earnings Scheduled For January 30, 2024
January 30, 2024
Companies Reporting Before The Bell • CommVault Systems (NASDAQ:CVLT) is estimated to report quarterly earnings at $0.73 per share on revenue of $208.06 million.
Via
Benzinga
Investor Optimism Improves Slightly Ahead Of Big Earnings, Fed's Policy Decision
January 30, 2024
The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the "Extreme Greed" zone on Monday.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Markets Stroll Higher Ahead Of Key Data; SMCI, FFIV, WHR Beat
January 29, 2024
One sign that we’re in a resilient bull market presently is that we’ve strolled into a potentially thorny period of economic and earnings data with market levels up more than a week straight, and we...
Via
Talk Markets
7 High-Yield Dividend Stocks With High-Upside Potential
January 29, 2024
With these enticing high-yield dividend stocks with potential for capital gains, investors can have their cake and eat it too.
Via
InvestorPlace
Pfizer's COVID-19 Treatment Paxlovid Will No Longer Be Available For Emergency Use After This Date, FDA Revises Label
January 29, 2024
FDA revises emergency use authorization for Pfizer's Paxlovid, impacting distribution and treatment of mild-to-moderate COVID-19. Transitions from March 8.
Via
Benzinga
Exposures
COVID-19
Product Safety
Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
January 29, 2024
Pfizer Inc. (NYSE: PFE) is expected to release earnings results for its fourth quarter, before the opening bell on Jan. 30, 2024.
Via
Benzinga
A Bull Market Is Here: 2 Cheap Stocks to Buy Right Now
January 29, 2024
The past few years have been a roller-coaster ride for these stocks.
Via
The Motley Fool
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
January 28, 2024
The stock is high risk, but rewards could be great if all works out well for Novavax.
Via
The Motley Fool
5 Magnificent Stocks to Buy That Are Dirt Cheap
January 28, 2024
Attractive valuations plus solid underlying businesses qualify these stocks as magnificent picks right now.
Via
The Motley Fool
2 Ultra-High-Yield Dividend Stocks Down 47% or More to Buy Hand Over Fist Right Now
January 27, 2024
These stocks could be poised to rebound in a big way.
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for Long-Term Income in 2024
January 26, 2024
The critical nature of services provided by these dividend stocks for long-term income support generation of predictable cashflows.
Via
InvestorPlace
3 Healthcare Stocks at 52-Week Lows: Buy or Bye?
January 26, 2024
Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.